Leishmania model for microbial virulence: The relevance of parasite multiplication and pathoantigenicity

Keyphrases

• Attenuation 33%
• Avirulent 33%
• B-cell Epitope 33%
• CD4+ 33%
• Cell Development 33%
• Clinical Symptoms 33%
• Cutaneous Disease 33%
• Cytolysis 100%
• Cytoplasmic Proteins 33%
• Emerging Infectious Diseases 33%
• Epitope 100%
• High Titer 33%
• Host Cell 33%
• Host Immune Response 33%
• Host Macrophages 33%
• Human Leishmaniasis 33%
• Ill-defined 33%
• Immune Response 33%
• Immunopathology 66%
• In Vitro System 33%
• Indian Kala-azar 33%
• Infectious Diseases 33%
• Intracellular Amastigotes 33%
• Intracellular Location 33%
• Intracellular Molecules 33%
• Intracellular Parasites 33%
• Leishmania 100%
• Leishmania Amazonensis 33%
• Leishmaniasis 33%
• Live Vaccine 33%
• Macrophage Cell Line 33%
• Macrophages 66%
• Microbial Virulence 100%
• Natural Infection 33%
• One-group 33%
• Operational Mechanism 33%
• Parasite Antigens 33%
• Parasite Molecules 33%
• Parasite Replication 33%
• Parasitophorous Vacuole 33%
• Potential Contribution 33%
• Secretory Products 33%
• Specific Antibodies 33%
• Specific Mechanisms 33%
• Surface Products 33%
• T Cell Epitope 33%
• Th2 Pathway 33%
• Virulence 66%

Immunology and Microbiology

• Amastigote 20%
• Antibodies 20%
• B Cell 20%
• CD4 20%
• Cell Maturation 20%
• Cytolysis 60%
• Epitope 100%
• Host Cell 20%
• Immune Response 20%
• Immune System 20%
• Immunology 20%
• Immunopathology 40%
• Infectious Disease 40%
• Intracellular Parasite 20%
• Leishmania 100%
• Leishmania amazonensis 20%
• Leishmaniasis 40%
• Macrophage 60%
• Macrophage Cell Line 20%
• Parasite Antigen 20%
• Parasitology 100%
• T Cell 20%
• Titer 20%
• Visceral Leishmaniasis 20%